Location History:
- Québec, CA (2019)
- Lasalle, CA (2016 - 2023)
Company Filing History:
4 out of 183 
1 out of 14 Years Active: 2016-2023
Title: The Innovative Contributions of Sébastien Lemieux
Introduction
Sébastien Lemieux is a notable inventor based in LaSalle, California. He has made significant contributions to the field of cancer immunotherapy, holding a total of four patents. His work focuses on identifying tumor-specific antigens and developing novel minor histocompatibility antigens.
Latest Patents
One of his latest patents is a proteogenomic-based method for identifying tumor-specific antigens. This method utilizes RNA-sequencing data from cancer and normal-matched samples to identify non-tolerogenic tumor-specific antigens. These antigens are crucial for the recognition and eradication of tumor cells by CD8 T cells. Another significant patent involves the description of novel minor histocompatibility antigens (MiHAs). These MiHAs are selected based on their minor allele frequency and tissue distribution, and they hold promise for applications in cancer immunotherapy, particularly for treating hematologic cancers such as leukemia.
Career Highlights
Sébastien Lemieux has worked with esteemed institutions, including the Université de Montréal and Rsem, Limited Partnership. His research has contributed to advancements in understanding tumor biology and improving cancer treatment strategies.
Collaborations
He has collaborated with notable colleagues such as Pierre Thibault and Claude Perreault, further enhancing the impact of his research in the scientific community.
Conclusion
Sébastien Lemieux's innovative work in identifying tumor-specific antigens and developing minor histocompatibility antigens showcases his commitment to advancing cancer immunotherapy. His contributions are paving the way for new treatment options in the fight against cancer.